Legal notices

Copyright notice

This website is the property of ClinSearch, a French company registered at the trade register of Nanterre (France) under the number B 422 455 386 and whose registered office is at 1 rue de l’Egalité, 92220 Bagneux, France. All components of this website (including registered trademarks, domain names, text, graphics, logotypes and photographs) are the exclusive property of ClinSearch. The website www.clinsearch.net is therefore protected by French and international laws covering intellectual property. Consequently, any reproduction and/or representation and/or distribution of the website, in whole or in part, through an existing or future electronic medium or other medium, is prohibited unless expressly authorised in advance by ClinSearch. Breach of this prohibition may give rise to civil and/or criminal liability for infringement of copyright.

Disclaimer

ClinSearch webmaster maintains this website to enhance public access to company information. Our goal is to keep this information timely and accurate. If errors are brought to our attention, we will try to correct them. However ClinSearch accepts no responsibility or liability whatsoever with regard to the information on this site.

This information is:

of a general nature only and is not intended to address the specific circumstances of any particular individual or entity;
not necessarily comprehensive, complete, accurate or up to date;
sometimes linked to external sites over which ClinSearch webmaster has no control and for which ClinSearch accepts no responsibility;
no professional or legal advice (if you need specific advice, you should always consult a suitably qualified consultant of our company).

Please note that we do not guaranty that an online document exactly replicates an officially adopted text. Only European Union legislation published in paper editions of the Official Journal of the European Union is deemed authentic.

It is our goal to minimize disruption caused by technical errors. However some data or information on our site may have been created or structured in files or formats that are not error-free and we cannot guarantee that our service will not be interrupted or otherwise affected by such problems. ClinSearch does not accept any responsibility with regards to such problems incurred as a result of using this site or any linked external site.

This disclaimer is not intended to limit the liability of ClinSearch in contravention of any requirements laid down in applicable national law nor to exclude its liability for matters which may not be excluded under that law.

Personal Data Protection

This website does not collect any personal data about its users. However, routine logging of site activity is performed (including IP address, referrer, user agent, time, and requested resource). This data is used for the sole purpose of producing summary statistics and detecting abuse. It is not communicated to any third party and destroyed within three months.

Changes to this Legal Notice

If this Legal Notice changes in any way, we will place an updated version of it on http://clinsearch.net/legal_notices.html. Regularly reviewing this page ensures that you are always aware of the information we collect, how we use it and under what circumstances, if any, we will share it with other parties.

Let clinical evidence
support innovation

Applications

News

Morning Read: Non-profit designing free Wi-Fi architecture for hospitals >> Read

Managing retinal vein occlusion >> Read

Let Me Die on the Prairie by Frances Jane Crosby Van Alstyne >> Read

Publication: Volume 16, number 4 (Stevenson). Study found that no conclusive results can be provided on the cost-effectiveness of four non-invasive tests for liver fibrosis [the Enhanced Liver Fibrosis Test, FibroTest and FibroMAX and transient elastography (FibroScan)] in patients suspected of having alcohol-related liver disease. >> Read

Top headlines from HIMSS2012 (Tuesday edition) >> Read

Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis >> Read

Publication: Volume 16, number 3 (Hockenhull). Report finds that whilst some interventions targeted at mental health populations to reduce violence are well supported by the evidence a scattergun approach in the research literature provides little firm evidence for the majority of interventions. Evidence shows small-to-moderate effects for cognitive behavioural therapy for psychological interventions, and larger effects for atypical antipsychotic drugs. >> Read

How the NHS measures up to other health systems >> Read

Publication: Volume 16, number 5 (Ara). Although orlistat, sibutramine and rimonabant are all effective at reducing weight and body mass index and, compared with placebo, are all cost-effective, both sibutramine and rimonabant have been withdrawn because of safety concerns relating to potential treatment-induced fatal adverse events. >> Read

Peter John Fenton >> Read

Publication: Volume 16, number 6 (Reeves). The verteporfin photodynamic therapy cohort study found that treatment and follow-up were much less frequent in routine clinical practice than in research trials and the cost-effectiveness was similar to the highest previous estimate. >> Read

Frederick Valentine Flynn >> Read